These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 26380236)
1. Evaluation of the circulating CD34(+), CD309(+), and endothelial progenitor cells in patients with first attack of optic neuritis. Etemadifar M; Dehghani L; Ganji H; Soleimani R; Talebi M; Eskandari N; Samani FS; Meamar R Adv Biomed Res; 2015; 4():151. PubMed ID: 26380236 [TBL] [Abstract][Full Text] [Related]
2. Impact of CD34/CD309 expression in circulating endothelial progenitor cells on prognosis and response to bortezomib therapy in multiple myeloma. ElMenshawy N; Ibrahim Fouda M; Mofreh M; Hisham El-Etriby H; O Elnenaei M; Eissa M J Immunoassay Immunochem; 2024 Sep; 45(5):481-491. PubMed ID: 39135454 [TBL] [Abstract][Full Text] [Related]
3. An association of serum vistafin level and number of circulating endothelial progenitor cells in type 2 diabetes mellitus patients. Berezin AE; Samura TA; Kremzer AA; Berezina TA; Martovitskaya YV; Gromenko EA Diabetes Metab Syndr; 2016; 10(4):205-212. PubMed ID: 27377688 [TBL] [Abstract][Full Text] [Related]
4. Absence of Correlation between Changes in the Number of Endothelial Progenitor Cell Subsets. Attar A; Aghasadeghi K; Parsanezhad ME; Namavar Jahromi B; Habibagahi M Korean Circ J; 2015 Jul; 45(4):325-32. PubMed ID: 26240587 [TBL] [Abstract][Full Text] [Related]
5. The role of endothelial progenitor cells in transient ischemic attack patients for future cerebrovascular events. Meamar R; Nikyar H; Dehghani L; Talebi M; Dehghani M; Ghasemi M; Ansari B; Saadatnia M J Res Med Sci; 2016; 21():47. PubMed ID: 27904593 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of Circulating Endothelial Progenitor Cells in Abdominal Aortic Aneurysms after Endovascular Aneurysm Repair. Wu W; Zhang J; Shao L; Huang H; Meng Q; Shen Z; Teng X Int J Stem Cells; 2022 May; 15(2):136-143. PubMed ID: 34711694 [TBL] [Abstract][Full Text] [Related]
7. Relationship between circulating endothelial progenitor cells and insulin resistance in non-diabetic patients with ischemic chronic heart failure. Berezin AE; Kremzer AA Diabetes Metab Syndr; 2014; 8(3):138-44. PubMed ID: 25082501 [TBL] [Abstract][Full Text] [Related]
8. Circulating CD34+, CD133+, and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid metaplasia. Massa M; Rosti V; Ramajoli I; Campanelli R; Pecci A; Viarengo G; Meli V; Marchetti M; Hoffman R; Barosi G J Clin Oncol; 2005 Aug; 23(24):5688-95. PubMed ID: 16110028 [TBL] [Abstract][Full Text] [Related]
9. [Content of circulating endothelial progenitor cells in patients with chronic ischemic heart failure with preserved left ventricular ejection fraction]. Berezin AE; Kremzer AA Kardiologiia; 2015; 55(1):14-22. PubMed ID: 26050484 [TBL] [Abstract][Full Text] [Related]
10. Relationship between circulating endothelial progenitor cells and endothelial dysfunction in children with type 1 diabetes: a novel paradigm of early atherosclerosis in high-risk young patients. Głowińska-Olszewska B; Moniuszko M; Hryniewicz A; Jeznach M; Rusak M; Dąbrowska M; Łuczyński W; Bodzenta-Łukaszyk A; Bossowski A Eur J Endocrinol; 2013 Feb; 168(2):153-61. PubMed ID: 23111589 [TBL] [Abstract][Full Text] [Related]
11. Circulating endothelial progenitor cells as markers for severity of ischemic chronic heart failure. Berezin AE; Kremzer AA J Card Fail; 2014 Jun; 20(6):438-47. PubMed ID: 24594088 [TBL] [Abstract][Full Text] [Related]
12. Recombinant human granulocyte-colony-stimulating factor-mobilized and apheresis-collected endothelial progenitor cells: a novel blood cell component for therapeutic vasculogenesis. Körbling M; Reuben JM; Gao H; Lee BN; Harris DM; Cogdell D; Giralt SA; Khouri IF; Saliba RM; Champlin RE; Zhang W; Estrov Z Transfusion; 2006 Oct; 46(10):1795-802. PubMed ID: 17002637 [TBL] [Abstract][Full Text] [Related]
13. Endothelial Progenitor Cells and NADPH Oxidase Enzyme Activity in the Development of an Aortic Aneurysm. Bingol B; Elcik D; Kutuk S; Özsoy S; Kelesoglu S; Tuncay A; Cetinkaya Z; Sulaiman J; Inanc MT; Kalay N; Koker MY Braz J Cardiovasc Surg; 2022 Aug; 37(4):501-510. PubMed ID: 35072395 [TBL] [Abstract][Full Text] [Related]
14. Increased total number but impaired migratory activity and adhesion of endothelial progenitor cells in patients on long-term hemodialysis. Herbrig K; Pistrosch F; Oelschlaegel U; Wichmann G; Wagner A; Foerster S; Richter S; Gross P; Passauer J Am J Kidney Dis; 2004 Nov; 44(5):840-9. PubMed ID: 15492950 [TBL] [Abstract][Full Text] [Related]
15. Rapid and selective mobilization of specific stem cell types after consumption of a polyphenol-rich extract from sea buckthorn berries ( Drapeau C; Benson KF; Jensen GS Clin Interv Aging; 2019; 14():253-263. PubMed ID: 30787601 [TBL] [Abstract][Full Text] [Related]
16. Concurrent hypermulticolor monitoring of CD31, CD34, CD45 and CD146 endothelial progenitor cell markers for acute myocardial infarction. Shim Y; Nam MH; Hyuk SW; Yoon SY; Song JM Anal Chim Acta; 2015 Jan; 853():501-507. PubMed ID: 25467496 [TBL] [Abstract][Full Text] [Related]
17. Brief report: impaired in vivo neovascularization capacity of endothelial progenitor cells in patients with systemic sclerosis. Kuwana M; Okazaki Y Arthritis Rheumatol; 2014 May; 66(5):1300-5. PubMed ID: 24782187 [TBL] [Abstract][Full Text] [Related]
18. The association of endothelial progenitor cell markers with arteriovenous fistula maturation in hemodialysis patients. Eroglu E; Kocyigit I; Saraymen B; Tuncay A; Mavili E; Unal A; Avcilar H; Koker MY; Oymak O Int Urol Nephrol; 2016 Jun; 48(6):891-9. PubMed ID: 27068816 [TBL] [Abstract][Full Text] [Related]
19. Elevated Inflammatory Parameter Levels Negatively Impact Populations of Circulating Stem Cells (CD133+), Early Endothelial Progenitor Cells (CD133+/VEGFR2+), and Fibroblast Growth Factor in Stroke Patients. Golab-Janowska M; Paczkowska E; Machalinski B; Kotlega D; Meller A; Safranow K; Wankowicz P; Nowacki P Curr Neurovasc Res; 2019; 16(1):19-26. PubMed ID: 30706812 [TBL] [Abstract][Full Text] [Related]
20. The Effect of Short-Term NAD3® Supplementation on Circulating Adult Stem Cells in Healthy Individuals Aged 40-70 Years. Hellenbrand J; Bloomer RJ; Van der Merwe M Cureus; 2024 Mar; 16(3):e55661. PubMed ID: 38590496 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]